Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Research and Clinical Diagnostic Tests and Controls
  4. Drug Monitoring and Testing
  5. Drugs of Abuse Clinical Controls and Calibrators
  6. 23111361

Germaine™ Laboratories AimScreen™ DOA Negative Control

Catalog No. 23111361
Change view
Click to view available options
Quantity:
1 x 5 mL
Catalog No. Quantity
23-111-361 1 x 5 mL
1 options
This item is not returnable. View return policy

Catalog No. 23-111-361

Supplier: Germaine™ Laboratories 40003

Due to product restrictions, please to purchase or view availability for this product.

This item is not returnable. View return policy

Description

Germaine™ Laboratories AimScreen™ DOA Negative Controls monitor and validate the performance of DOA detection methods at levels established by SAMHSA, CAP/AACC and many state programs

  • Compatible with all quantitative and qualitative drug detection procedures which are sufficiently sensitive to detect the control constituents
  • Should be treated as any unknown specimen while following the specific protocol of the assay being used
  • Controls prepared from human based urine available as a negative
  • Cutoff is +3x to monitor the performance of drugs of abuse test devices
  • Each bottle contains stabilized human based urine
  • Human urine based matrix

Specifications

Content And Storage 2°C to 8°C
Detectable Analytes Negative Control
For Use With (Equipment) All quantitative and qualitative drug detection procedures which are sufficiently sensitive to detect the control constituents.
Quantity 1 x 5 mL
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.